These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7120057)

  • 1. Square root of time dependence of matrix formulations with low drug content.
    Fessi H; Marty JP; Puisieux F; Carstensen JT
    J Pharm Sci; 1982 Jul; 71(7):749-52. PubMed ID: 7120057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets.
    Gil EC; Colarte AI; Bataille B; Caraballo I
    AAPS PharmSciTech; 2007 Dec; 8(4):E115. PubMed ID: 18181536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-unit dosage formulations of theophylline for controlled release applications.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(6):553-9. PubMed ID: 18323251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of radioprotective agents from matrix tablets--effect of preparative conditions on release rates.
    Benita S; Shani J; Abdulrazik M; Samuni A
    J Pharm Pharmacol; 1984 Apr; 36(4):222-8. PubMed ID: 6144767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of floating bilayer tablets of diltiazem hydrochloride and lovastatin.
    Kulkarni AS; Bhatia MS
    PDA J Pharm Sci Technol; 2008; 62(5):344-52. PubMed ID: 19055230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Process analytical technology: chemometric analysis of Raman and near infra-red spectroscopic data for predicting physical properties of extended release matrix tablets.
    Shah RB; Tawakkul MA; Khan MA
    J Pharm Sci; 2007 May; 96(5):1356-65. PubMed ID: 17455359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride.
    Patra CN; Kumar AB; Pandit HK; Singh SP; Devi MV
    Acta Pharm; 2007 Dec; 57(4):479-89. PubMed ID: 18165191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of excipients on the release kinetics of diclofenac sodium and papaverine hydrochloride from composed tablets.
    Kasperek R; Trebacz H; Zimmer Ł; Poleszak E
    Acta Pol Pharm; 2014; 71(3):439-49. PubMed ID: 25265824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
    Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
    Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
    Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
    Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process.
    Patil H; Tiwari RV; Upadhye SB; Vladyka RS; Repka MA
    Int J Pharm; 2015 Dec; 496(1):33-41. PubMed ID: 25863118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.